Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers 'a major step' closer to river blindness vaccine
Blackfly
River blindness is spread by blackflies that breed in rivers.

Disease affects around 17 million people worldwide

Researchers have taken a major step towards developing the world's first vaccine against river blindness.

Scientists at the University of Edinburgh say that a vaccination would end a 30 year quest to beat the disease, which affects around 17 million people across the globe.

Over 90 per cent of cases of river blindness occur in west and central Africa.  The disease is caused by infection with the parasitic worm Onchocerca volvulus and is spread by blackflies that breed in rivers.

Around 10 per cent of those infected go on to develop eye conditions, one per cent become blind, and 70 per cent develop very severe skin diseases which can lead to social exclusion.  

Current control of river blindness relies on mass distribution of a drug called ivermectin, which has been successful in reducing incidence of the condition wherever it has been used. However, children under five - who comprise up to 20 per cent of the population in endemic regions - are excluded from the treatment.

Now, scientists from the University of Edinburgh's Division of Infection and Pathway Medicine have identified three potential vaccine compounds the could offer protection against the disease.

They hope to take at least one of these potential vaccines to safety trials, and to test its effectiveness by 2025.  Eventually they hope to administer a vaccine to children as part of national immunisation programmes.

Commenting on the study, lead researcher professor David W Taylor, said: "New knowledge of the way nematode parasites regulate people's immune responses has guided formulation of experimental vaccines.

"A vaccine for river blindness would compliment and augment existing treatment and significantly improve the prospects for eliminating this disease from Africa."

The research initiative - The Onchocerciasis Vaccine for Africa (TOVA) - was launched in response to the London Declaration on Neglected Tropical Diseases which called for tools to eliminate river blinds from Africa.

TOVA builds on over 30 years of research by Academics from Edinburgh and researchers in Africa, Europe, and the US and involves 15 organisations across five countries.

Image (C) Wikimedia commons

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.